Most vulnerable HCV patient groups treated with direct acting antivirals achieve high response rates and gain quality of life – Data from the German Hepatitis C-Registry (DHC-R)

S. Christensen, A. Stoehr, G. Teuber, J. Petersen, R. Link, U. Naumann, C. John, K.-G. Simon, Y. Serfert, S. Zeuzem, H. Wedemeyer · Zeitschrift für Gastroenterologie · 2023 · Heft 08 · S. e458